Sjaastad O, Aasly J, Fredriksen T, Wysocka Bakowska M M
Cephalalgia. 1986 Jun;6(2):113-23. doi: 10.1046/j.1468-2982.1986.0602113.x.
In four patients with chronic paroxysmal hemicrania, two of whom could precipitate attacks mechanically, various autonomic function tests were carried out in connection with attacks. Not all features could be studied in all patients. Forehead sweating and temperature were measured. Sweating, tearing, and nasal secretion were studied after systemic atropine administration, which reduced attack-related sweating, tearing, and nasal secretion markedly. Intra-ocular pressure was measured before and after the topical administration of an alpha-receptor blocking agent, thymoxamine. After topical thymoxamine no definite intra-ocular pressure increase occurred during precipitated attacks. In attacks precipitated by head movements, forehead sweating occurred seconds (up to 30 sec) before the pain. This study indicates that at least in some CPH cases, forehead sweating is not caused by the pain. Nor is the pain secondary to increase in intra-ocular pressure. The thymoxamine experiments seem to indicate that alpha-receptors in some way may be connected with the intra-ocular pressure increase during attack.
在4例慢性阵发性偏侧头痛患者中,其中2例可通过机械刺激诱发发作,针对发作进行了各种自主神经功能测试。并非所有患者都能进行所有项目的研究。测量了额头出汗情况和温度。在全身给予阿托品后,对出汗、流泪和鼻部分泌物进行了研究,阿托品可显著减少与发作相关的出汗、流泪和鼻部分泌物。在局部应用α受体阻滞剂噻吗洛尔前后测量眼压。局部应用噻吗洛尔后,在诱发发作期间未出现明确的眼压升高。在因头部运动诱发的发作中,额头出汗在疼痛出现前几秒(最长30秒)就已发生。这项研究表明,至少在某些慢性阵发性偏侧头痛病例中,额头出汗不是由疼痛引起的。疼痛也不是眼压升高的继发症状。噻吗洛尔实验似乎表明,α受体可能以某种方式与发作期间的眼压升高有关。